Opportunity
SAM #d572a6e9dd854eee8812d6e0bf48c650
Sources Sought: Multiple Award IDIQ Construction Services at Frederick National Laboratory for Cancer Research
Buyer
National Institutes of Health
Posted
August 13, 2026
Respond By
September 18, 2026
Identifier
d572a6e9dd854eee8812d6e0bf48c650
NAICS
236220, 238910, 237990
This is a sources sought notice for construction services at the Frederick National Laboratory for Cancer Research (FNLCR), managed by Leidos Biomedical Research, Inc. (Leidos Biomed) under contract with the National Cancer Institute (NCI). - The opportunity is for a Multiple Award Indefinite Delivery/Indefinite Quantity (IDIQ) contract. - Scope includes a broad range of construction services to support FNLCR operations. - No specific Original Equipment Manufacturers (OEMs), products, or part numbers are identified. - No quantities or detailed technical requirements are provided in the notice. - Interested parties are directed to obtain further details via a provided link or by contacting the Leidos Biomed Contracts Manager. - This is a market research/sources sought announcement, not a solicitation for bids or proposals at this stage. - No estimated contract value or period of performance is specified in the notice.
Description
National Institutes of Health, National Cancer Institute, Frederick National Laboratory for Cancer Research Opportunities-Special Announcements: Frederick National Laboratory for Cancer Research (FNLCR) Operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute requires an Indefinite Delivery/Indefinite Quantity Subcontract for construction services for the Frederick National Laboratory for Cancer Research (FNLCR).
To obtain a copy of the Sources Sought please click the following link: https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/multiple-award-idiq-construction-contract-fnlcr
or email Leidos Biomedical Research POC: Contracts Manager, Matthew Hull @ matthew.hull@nih.gov
Background Information: Leidos Biomedical Research, Inc. (Leidos Biomed), a subsidiary of Leidos Corporation, a Delaware corporation with offices in Frederick, MD is the Operations and Technical Support (OTS) contractor for the National Cancer Institute at Frederick. The effort to be performed will be part of Leidos Biomed’s Prime Contract 75N91019D00024 that has been issued by the National Cancer Institute, National Institutes of Health, Frederick, MD.
Leidos Biomedical Research, Inc. POC: Contracts Manager at matthew.hull@nih.gov
For information concerning other opportunities with the FNLCR, please refer to: https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/multiple-award-idiq-construction-contract-fnlcr or contact the Leidos Biomedical Research Point of Contact listed in this announcement.